PUBLISHER: The Business Research Company | PRODUCT CODE: 1946719
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946719
Patient blood management is a patient-centered, evidence-based, and systematic approach to improving the care of individuals who may require a blood transfusion by optimizing the patient's blood levels, reducing surgical blood loss, and utilizing the body's physiological tolerance to anemia, thereby decreasing the need for donated blood transfusions.
The patient blood management market is segmented by product into instruments, accessories, reagents and kits, and software solutions. Patient blood management kits are used to optimize and manage a patient's blood resources. The market is further segmented by component into plasma, whole blood, and red blood cells, which are used across applications such as hospitals, clinics, and others.
Tariffs have moderately impacted the patient blood management market by increasing costs for imported instruments, reagents, and software systems used in blood monitoring and diagnostics. Hospitals in asia-pacific and latin america relying on imported blood management devices face procurement delays and higher pricing, particularly across instruments and reagents segments. However, tariffs are encouraging domestic manufacturing, local sourcing, and regional partnerships, which may strengthen supply resilience and cost optimization over the long term.
The patient blood management market research report is one of a series of new reports from The Business Research Company that provides patient blood management market statistics, including patient blood management industry global market size, regional shares, competitors with a patient blood management market share, detailed patient blood management market segments, market trends and opportunities, and any further data you may need to thrive in the patient blood management industry. This patient blood management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The patient blood management market size has grown marginally in recent years. It will grow from $15.94 billion in 2025 to $15.95 billion in 2026 at a compound annual growth rate (CAGR) of 0.1%. The growth in the historic period can be attributed to rising surgical volumes, blood supply shortages, transfusion-related complications awareness, hospital cost containment pressure, clinical guideline standardization.
The patient blood management market size is expected to see strong growth in the next few years. It will grow to $22.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to aging population growth, elective surgery growth, stricter transfusion regulations, value-based healthcare adoption, expansion of pbm in emerging markets. Major trends in the forecast period include preoperative anemia screening protocols, point-of-care hemoglobin testing, standardized transfusion guidelines adoption, multidisciplinary PBM programs in hospitals, increased clinician education on PBM.
The increasing number of surgical procedures is increasingly supporting the expansion of the patient blood management market going forward. Surgical procedures involve the physical manipulation of tissues or organs to diagnose, treat, or prevent medical conditions and often require incisions and specialized instruments. The growth in surgical volumes is linked to the rising prevalence of chronic diseases, advancements in medical technology, improved surgical techniques, and aging populations. Patient blood management enhances surgical care by optimizing blood utilization, reducing the need for transfusions, minimizing complications, and improving outcomes through effective anemia management and preoperative assessment. For example, in August 2023, according to The Aesthetic Society, a US-based organization representing plastic surgery and cosmetic medicine professionals, Americans spent over $11.8 billion on aesthetic procedures, reflecting a 2% increase compared to 2022. Consequently, the growing number of surgical procedures is contributing to the expansion of the patient blood management market.
Leading companies operating in the patient blood management market are focusing on innovative medical devices for blood transfusions to strengthen market revenues. Blood transfusion devices are designed to safely and efficiently collect, process, and deliver blood products to patients. For example, in May 2024, Becton, Dickinson, and Company launched UltraTouch, a device engineered to simplify blood sample collection while minimizing patient discomfort. The device enables efficient venipuncture, improves sample accuracy, incorporates ergonomic design features, and includes safety mechanisms to reduce needle-stick injuries, enhancing both patient and clinician experience.
In December 2024, GVS S.p.A., an Italy-based medical device and filtration company, acquired the transfusion medicine business of Haemonetics Corporation. Through this acquisition, GVS seeks to strengthen its position in the healthcare filtration sector and expand its global footprint by integrating Haemonetics' proprietary solutions for blood collection, processing, filtration, and transfusion. Haemonetics Corporation is a US-based company specializing in transfusion medicine and blood management solutions.
Major companies operating in the patient blood management market are Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMerieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc, Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Grifols Diagnostic Solutions Inc., HemoCue AB
North America was the largest region in the patient blood management market in 2025. Western Europe was the second-largest region in the patient blood management market share. The regions covered in the patient blood management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the patient blood management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The patient blood management market includes revenues earned by instruments, blood processing devices, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Patient Blood Management Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses patient blood management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for patient blood management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The patient blood management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.